Antidepressant-warfarin interaction and associated gastrointestinal bleeding risk in a case-control study.
Bleeding is the most common and worrisome adverse effect of warfarin therapy. One of the factors that might increase bleeding risk is initiation of interacting drugs that potentiate warfarin. We sought to evaluate whether initiation of an antidepressant increases the risk of hospitalization for gast...
Main Authors: | Hedi Schelleman, Colleen M Brensinger, Warren B Bilker, Sean Hennessy |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2011-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3123326?pdf=render |
Similar Items
-
Correction: antidepressant-warfarin interaction and associated gastrointestinal bleeding risk in a case-control study.
by: PLOS ONE Staff
Published: (2015-01-01) -
Risk of Gastrointestinal Bleeding Associated with Potentially Significant Warfarin Drug Interactions
by: Ru-Fen Chen, et al.
Published: (2010) -
Evaluation of serious bleeding signals during concomitant use of clopidogrel and hypnotic drugs
by: Thanh Phuong Pham Nguyen, et al.
Published: (2021-07-01) -
Risk of Gastrointestinal Bleeding with Rivaroxaban: A Comparative Study with Warfarin
by: Muhammed Sherid, et al.
Published: (2016-01-01) -
Warfarin: pharmacological profile and drug interactions with antidepressants
by: Juliana Souto Teles, et al.
Published: (2012-03-01)